Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Pharmaceutical Outsourcing Present and Future

The need for preclinical testing expertise is growing as molecular complexity increases.

Navigating the Preclinical CRO Outsourcing Process

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

A Closer Look at Affinity Ligands

Topic

Shriya Bhatkhande is a research associate at BioPlan Associates.

Articles

Growth in outsourcing has been the result of COVID-19 projects taking 
precedence, which has pushed some contract manufacturing to second-tier CDMOs. 

Biopharmaceutical Manufacturing Growth

Ashley Wentworth is senior director, Vault Quality, at Veeva Systems.

In the coming year, pharmaceutical innovation will be fueled by key trends throughout the quality sector.

Forecasting Trends in Pharma Innovation

The complexity of the pharmaceutical product brings challenges to the transfer of information and technology between sponsors and contractors.

Communication is Key in Complex Tech Transfer

Kai Lipinski, PhD, is the chief scientific officer of Vibalogics.

Although new single-use technologies offer the flexibility needed to overcome several challenges in ATMP production, there are many considerations and hurdles manufacturers must be aware of when scaling. 

Scaling Manufacturing Processes Using  Single-Use Technologies

CBM’s plasmid manufacturing offering is designed to provide phase-appropriate plasmids on demand for companies working on cell and gene therapies.

The Center for Breakthrough Medicines Announces Plasmid Manufacturing Service

Be the Match BioTherapies’ and CIBMTR’s expanded service offering is intended to aid in the design, implementation, and oversight of cellular therapy clinical trials.

Be The Match BioTherapies Launches CRO Services for Cell and Gene Therapy

Agilent’s $725 million investment is designed to double its capacity to produce APIs.

Agilent Invests $725 Million in Nucleic Acid-based Therapeutics

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Podcasts

Public relations agencies dissect pharmaceutical trends: Brandwidth Solutions, Orientation Marketing and White Matter Communications

Drug Solutions Podcast: Pharma Trends Dissected by 3 PR Agency Luminaries

CMOs are hoping to grow outsourcing to significantly higher levels in many different areas, with a focus on analytical testing, toxicity testing, and fill/finish operations.

The Growth and Emergence of Technology in the Outsourcing Space

Meg Rivers is the former senior editor for 

In this episode of the Drug Solutions Podcast, Meg Rivers discusses outsourcing strategies in biopharma with Jeff Henderson, key account manager of Vetter.